CyberLogic, Inc.

HEDIS OMW Compliance Guide Contact Us

HEDIS OMW Compliance Guide

Osteoporosis Management in Women Who Had a Fracture – Using UltraScan 650 to support quality measures.


UltraScan 650 Overview

What Is HEDIS OMW?

HEDIS OMW (Osteoporosis Management in Women Who Had a Fracture) is a national quality measure that evaluates whether women aged 67–85 who suffer a fracture receive appropriate osteoporosis management within 180 days. Compliance is met when the patient receives either a bone mineral density (BMD) test or osteoporosis medication in that timeframe.

This measure is used in Medicare Advantage, CMS Star Ratings, and value‑based care programs to assess the quality of osteoporosis care and fracture follow‑up.



Which Patients Are Included?

HEDIS OMW applies to:

  • Women aged 67–85
  • With a qualifying fracture event
  • Excluding fractures of the finger, toe, face, and skull

Once a qualifying fracture is identified, the clinic has 180 days to provide osteoporosis management that meets the measure requirements.



What Counts as Compliance?

A patient meets HEDIS OMW compliance if, within 180 days after the fracture, she receives:

  • A bone mineral density (BMD) test, or
  • An osteoporosis medication

Clinics typically use DXA or equivalent BMD testing and standard osteoporosis medications. Radiation‑free BMD testing options, such as UltraScan 650, can be integrated into this workflow.



How UltraScan 650 Supports HEDIS OMW

UltraScan 650 is an FDA‑approved, radiation‑free bone densitometer that provides DXA‑equivalent accuracy at the forearm. Clinics can use UltraScan 650 as part of their osteoporosis management strategy for patients who meet HEDIS OMW criteria.

  • Radiation‑free BMD measurement
  • Approximately 10‑second scan time
  • Portable and suitable for mobile screening
  • DXA‑equivalent accuracy validated in clinical studies
View Clinical Validation


Suggested Clinical Workflow for OMW

Clinics can use the following workflow to support HEDIS OMW compliance:

  1. Identify Fracture: Confirm a qualifying fracture in women aged 67–85.
  2. Flag for OMW: Mark the patient for osteoporosis management within 180 days.
  3. Order BMD Test: Schedule a DXA or UltraScan 650 BMD test.
  4. Review Results: Interpret BMD values and assess fracture risk.
  5. Initiate Treatment: Prescribe osteoporosis medication when clinically appropriate.
  6. Document Care: Ensure the BMD test or medication is recorded in the EMR.


Coding & Documentation Tips

Accurate coding and documentation are essential for HEDIS OMW compliance. Clinics should:

  • Use appropriate fracture diagnosis codes
  • Record BMD testing with the correct procedure codes
  • Document osteoporosis medication prescriptions
  • Ensure dates of fracture and management are clearly captured

Consult your health plan or quality department for specific coding guidance and measure specifications.



Patient Communication

Clinics can improve OMW performance by clearly explaining osteoporosis management to patients:

  • Emphasize the importance of bone health after a fracture.
  • Explain that BMD testing helps assess fracture risk.
  • Highlight that UltraScan 650 is radiation‑free and quick.
  • Discuss medication options when appropriate.


Contact CyberLogic

If your clinic requires additional materials, validation documents, or workflow guidance for HEDIS OMW, please contact us.

Contact CyberLogic